1. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and UASSG. Shooting up; infections among injecting drug users in the United Kingdom 2004: an update, October 2005. London: Health Protection Agency, 2005.
3. Weild, AR, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a National Survey. Communicable Disease and Public Health 2000; 3: 121–126.
4. Sutton, AJ, et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection 2006; 134: 231–242.
5. Gore, SM, et al. Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. International Journal of STD & AIDS 1997; 3: 166–175.
6. Allwright, S, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. British Medical Journal 2000; 321: 78–82.
7. Vong, S, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis a outbreak among methamphetamine drug users. Vaccine 2005; 23: 1021–1028.
8. Gilbert, RL, et al. Hepatitis A vaccination – a prison-based solution for a community-based outbreak? Communicable Disease and Public Health 2004; 7: 289–293.
9. Gilbert, RL, et al. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Communicable Disease and Public Health 2004; 7: 306–311.
10. Hutchinson, SJ, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004; 23: 210–214.
11. Sutton, AJ, Gay, NJ, Edmunds, WJ. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine 2006; 24: 2377–2386.
12. Weinbaum, CM, Sabin, KM, Santibanez, SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005; 19 (Suppl. 3): S41–S46.
13. Bird, AG, et al. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995; 9: 801–808.
14. Sutton, AJ, et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infectious Diseases 2006; 6: 93.